LifeTech Financial Statements From 2010 to 2025
| LFTSF Stock | USD 0.23 0.00 0.00% |
Check LifeTech Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeTech Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . LifeTech financial statements analysis is a perfect complement when working with LifeTech Scientific Valuation or Volatility modules.
LifeTech |
LifeTech Scientific Company Return On Asset Analysis
LifeTech Scientific's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current LifeTech Scientific Return On Asset | 0.073 |
Most of LifeTech Scientific's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LifeTech Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, LifeTech Scientific has a Return On Asset of 0.073. This is 100.83% lower than that of the Healthcare sector and 100.4% lower than that of the Medical Devices industry. The return on asset for all United States stocks is 152.14% lower than that of the firm.
LifeTech Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LifeTech Scientific's current stock value. Our valuation model uses many indicators to compare LifeTech Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LifeTech Scientific competition to find correlations between indicators driving LifeTech Scientific's intrinsic value. More Info.LifeTech Scientific is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LifeTech Scientific is roughly 1.55 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LifeTech Scientific's earnings, one of the primary drivers of an investment's value.About LifeTech Scientific Financial Statements
LifeTech Scientific stakeholders use historical fundamental indicators, such as LifeTech Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although LifeTech Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in LifeTech Scientific's assets and liabilities are reflected in the revenues and expenses on LifeTech Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LifeTech Scientific. Please read more on our technical analysis and fundamental analysis pages.
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the Peoples Republic of China. Lifetech Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1144 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in LifeTech Pink Sheet
LifeTech Scientific financial ratios help investors to determine whether LifeTech Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LifeTech with respect to the benefits of owning LifeTech Scientific security.